Contact Us
NeoVas™ Sirolimus-eluting Bioresorbable Coronary Scaffold System
NeoVas™ Sirolimus-eluting Bioresorbable Coronary Scaffold System
NeoVas™ Sirolimus-eluting Bioresorbable Coronary Scaffold System

NeoVas™ Sirolimus-eluting Bioresorbable Coronary Scaffold System

NeoVas™

NeoVas™ Sirolimus-eluting Bioresorbable Coronary Scaffold System Details


Stent Platform


  • Fully degradable poly(L-lactide)

  • Sine wave structure in space, In-phase peak-valley connection


Drug coating


  •  Fully degradable poly(D,L-lactide)

  •  Effectively control sirolimus release rate


Drug


  • Classical Sirolimus with dose of 15.3ug/mm

  •  Inhibit the proliferation and migration of smooth muscle cells


Delivery system


  • Completely self-developed second-generation rapid-exchange balloon dilatation catheter

  • Superior pushability and crossability

Ordering Information

Specifications

Clinical Data

Stent Diameter
(mm)
Stent Length (mm)
1215182124
2.75LPS2712LPS2715LPS2718LPS2721LPS2724
3LPS3012LPS3015LPS3018LPS3021LPS3024
3.5LPS3512LPS3515LPS3518LPS3521LPS3524


Balloon Diameter
(mm
Pressure kPa (atm)
203
(2)
405
(4)
608
(6)
709
(7)
810
(8)
1013
(10)
1216
(12)
1418
(14)
1621
(16)
1824
(18)
2027
(20)
2.752.62.662.712.732.752.822.882.9433.063.12
32.842.892.952.9733.063.123.183.253.33.36
3.53.373.423.473.53.543.613.683.753.813.883.95


NeoVas RCT Study

The study enrolled 560 subjects in 33 centers from China, Test group(NeoVas) 278 cases,  Control group (Xience stent) 282 cases.


The importance of standardized PSP operations

Experience: Standardized PSP operation ensures safety for Neovas Scaffold.

The application rate of PSP operation is relatively low in Absorb Ⅱ and Absorb Ⅲ study, 

the TLF and stent thrombus of BVS in three years is relatively high, displays statistical difference with metal stent; the PSP operation perform rate in Absorb China study is relatively high, the TLF and stent thrombus of BVS in three years is relatively low and has no statistical difference with metal stent.


Provide Total Solution For
Patients With
Cardiovascular Disease
Email us with any questions or inquiries or use our contact data. We would be happy to answer your questions.